Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular uptake of thyroid hormones is the process by which thyroxine (T4) and triiodothyronine (T3) are transported from the bloodstream into target cells via carrier-mediated processes involving specific membrane transporters like MCT8, OATPs, and LATs. This uptake is crucial for maintaining appropriate intracellular hormone concentrations, especially for active T3, and for thyroid hormones to exert their biological effects by interacting with nuclear receptors and regulating gene expression. Impaired transporter function can lead to cellular hypothyroidism, even with normal serum levels, contributing to various conditions like insulin resistance and neurodegenerative diseases. The pituitary gland's unique transporter profile can mask peripheral tissue hypothyroidism in standard serum TSH measurements.
Modulation of thyroid hormone transport into cells, influencing intracellular T3/T4 concentrations and downstream effects on gene transcription and metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular Uptake of Thyroid Hormones (TH Uptake).